Therapeutic Mechanisms of Jinshuiqing in IgA Nephropathy: A Transcriptomic Analysis
Medical Science Monitor Basic Research · 2025
DOI: 10.12659/msmbr.950343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor Basic Research, 2025. Verfasst von Zhijian Zha und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Hubei University of Chinese Medicine, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND This study aims to explore the therapeutic mechanisms of Jinshuiqing (JSQ) in IgA nephropathy (IgAN) using transcriptomic analysis and animal experimentation. MATERIAL AND METHODS Six-week-old male C57BL/6 mice (20±2 g) were divided into 2 groups: IgAN model and JSQ-treated. The IgAN model was induced in SIRT3 knockout mice with acidified BSA, CCl4, castor oil, and LPS injections. The IgAN group received saline, while the JSQ group was treated with JSQ (4 g/kg/day) for 11 weeks. Following euthanasia, kidney tissues were collected for transcriptomic analysis. RNA extraction and sequencing were performed, followed by differential gene expression and pathway enrichment analysis to assess JSQ's effects. RESULTS PCA and correlation analysis showed distinct differences between the JSQ-treated and control groups. Differential gene expression identified 118 genes with significant changes, indicating that JSQ induces transcriptional alterations. Gene ontology (GO) and KEGG enrichment analyses revealed that JSQ affects pathways related to inflammation, oxidative stress, and metabolism, suggesting its potential to improve kidney function and regulate immune responses in IgAN. CONCLUSIONS JSQ treatment modulates gene expression in IgAN mice, influencing pathways linked to inflammation, gut microbiota, and kidney function. These findings provide insight into how JSQ alleviates inflammation and promotes renal health, offering genetic evidence for its therapeutic efficacy in IgAN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- First Clinical Medical College, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China.
- Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- Hubei Sizhen Laboratory, Wuhan, Hubei, China.
Zitieren
APA
Zha, Z., Song, W., Wang, R., Zhang, X., Liu, X., & Wang, L. (2025). Therapeutic Mechanisms of Jinshuiqing in IgA Nephropathy: A Transcriptomic Analysis. Medical Science Monitor Basic Research. https://doi.org/10.12659/msmbr.950343
Vancouver
Zha Z, Song W, Wang R, Zhang X, Liu X, Wang L. Therapeutic Mechanisms of Jinshuiqing in IgA Nephropathy: A Transcriptomic Analysis. Medical Science Monitor Basic Research. 2025. doi:10.12659/msmbr.950343
BibTeX
@article{Zha2025,
author = {Zha, Zhijian and Song, Wenzhu and Wang, Rui and Zhang, Xuerong and Liu, Xiaoying and Wang, Linqun},
title = {Therapeutic Mechanisms of Jinshuiqing in IgA Nephropathy: A Transcriptomic Analysis},
journal = {Medical Science Monitor Basic Research},
year = {2025},
doi = {10.12659/msmbr.950343}
}
EUVIMED